Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,022 | 0,034 | 18:34 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.12.24 | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | 3 | Stockwatch | ||
16.12.24 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Q3 2024 Financial Results and Operational Update | 1 | TheNewswire | ||
STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
01.10.24 | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Q2 2024 Financial Results and Operational Update | 5 | TheNewswire | ||
09.07.24 | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order | 684 | ACCESS Newswire | TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
04.07.24 | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order | 424 | ACCESS Newswire | TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
23.05.24 | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Failure to File Cease Trade Order | 553 | ACCESS Newswire | TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
17.05.24 | StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update | 1.390 | ACCESS Newswire | TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for... ► Artikel lesen | |
10.04.24 | XFRA 61N1: AUSSETZUNG/SUSPENSION | 256 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSTAGEZERO LIFE SCIENC.... ► Artikel lesen | |
05.04.24 | StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order | 524 | ACCESS Newswire | TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
03.04.24 | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results | 449 | ACCESS Newswire | TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
CARL ZEISS MEDITEC | 54,85 | -0,09 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Carl Zeiss Meditec auf "Neutral" mit einem Kursziel von 50 Euro belassen. US-Investoren begegneten europäischen Herstellern... ► Artikel lesen | |
INTUITIVE SURGICAL | 565,80 | -0,32 % | $100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today | ||
BOSTON SCIENTIFIC | 101,00 | -0,98 % | Boston Scientific Aktie: Wegweisender Erfolg erzielt! | Die Aktie des Medizintechnikunternehmens Boston Scientific verzeichnet derzeit eine bemerkenswerte Entwicklung, während mehrere hochrangige Führungskräfte bedeutende Aktienverkäufe durchführen. Der... ► Artikel lesen | |
PLUS THERAPEUTICS | 1,058 | -8,95 % | Plus Therapeutics Announces Renewal Of Master Services Agreement With Telix | CANBERA (dpa-AFX) - Plus Therapeutics (PSTV) announced the renewal of its Master Services Agreement with Telix IsoTherapeutics Group. The MSA secures supply of cGMP Re-186, the radioisotope... ► Artikel lesen | |
MOUNTAIN VALLEY MD | 0,015 | -19,15 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
LIFEWARD | 2,180 | +10,66 % | Lifeward Ltd. - S-1/A, General form for registration of securities | ||
SENSEONICS | 1,180 | +0,21 % | Senseonics erwartet leicht gestiegene Verluste im jüngsten Quartal | ||
EKSO BIONICS | 0,572 | +4,00 % | Ekso Bionics Holdings, Inc.: NSM Named Exclusive Distributor of Ekso Indego Personal Within the CRT Industry | ||
IMUNON | 0,850 | -0,58 % | Imunon, Inc.: IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer | Dr. Faller joins IMUNON with more than 30 years of industry, academic and laboratory experience, with specialized expertise in oncology and immunology LAWRENCEVILLE, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
ROCKWELL MEDICAL | 1,772 | +0,23 % | ROUNDUP/Aktien New York: Erneute Dow-Verluste - Nasdaq-Rally pausiert | NEW YORK (dpa-AFX) - An den US-Börsen bahnt sich am Dienstag für den Dow Jones Industrial der neunte Schwächetag in Folge an. Anders als zuletzt wird der US-Leitindex dabei aber von den anderen US-Indizes... ► Artikel lesen | |
AVINGER | 0,465 | -22,17 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
MEMPHASYS | 0,005 | 0,00 % | Hot Stocks: CSL, Breville Group, Memphasys, Critica | ||
VIRIDIAN THERAPEUTICS | 16,200 | +3,85 % | Viridian Therapeutics (NASDAQ:VRDN) Trading Down 5% - Here's Why |